Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (10931)
  2. Meeting Abstract (9499)
  3. Review (556)
  4. Book Section (417)
  5. Editorial (336)
  6. Guidelines (158)
  7. Correspondence (118)
  8. Conference Paper (107)
  9. Research Letter (61)
  10. Miscellaneous (54)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22241)
  2. GSK Faculty (5929)
  3. Genitourinary Oncology Service (5650)
  4. Survivorship Research (5226)
  5. Gastrointestinal Oncology Service (4692)
  6. Breast Medicine Service (4155)

More Groups

People
  1. Robert Motzer (1247)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (872)
  6. Leonard Saltz (792)

More People

Years
  1. 2025 (641)
  2. 2024 (1388)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5288)
  2. Annals of Oncology (1297)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (776)
  5. Journal of Thoracic Oncology (532)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5580)
  2. Elsevier Inc. (2662)
  3. American Association for Cancer Research (2327)
  4. Oxford University Press (1819)
  5. Nature Publishing Group (1043)
  6. Springer (981)

More Publishers

Results (22264)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A review of mitotane in the management of adrenocortical cancer
    Review

    Del Rivero, J.; Else, T.; Hallanger-Johnson, J.; Kiseljak-Vassiliades, K.; Raj, N.; Reidy-Lagunes, D.; Srinivas, S.; Gilbert, J.; Vaidya, A.; Aboujaoude, E.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • A multimodal neural network with gradient blending improves predictions of survival and metastasis in sarcoma
    Journal Article

    Bozzo, A.; Hollingsworth, A.; Chatterjee, S.; Apte, A.; Deng, J.; Sun, S.; Tap, W.; Aoude, A.; Bhatnagar, S.; Healey, J. H.
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy of axitinib in a US cohort of patients with programmed cell death protein 1-resistant mucosal melanoma
    Journal Article

    Lochrin, S. E.; Cugliari, M. K.; Yeh, R.; Shoushtari, A. N.
    Melanoma Research (2024)

    Fulltext@MSK | Save
  • Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): A randomised, double-blind, placebo-controlled, phase 3 trial
    Journal Article

    Spicer, J. D.; Garassino, M. C.; Wakelee, H.; Liberman, M.; Kato, T.; Tsuboi, M.; Lee, S. H.; Chen, K. N.; Dooms, C.; Majem, M.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • (177)Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): A phase 3, randomised, controlled trial
    Journal Article

    Morris, M. J.; Castellano, D.; Herrmann, K.; de Bono, J. S.; Shore, N. D.; Chi, K. N.; Crosby, M.; Piulats, J. M.; Fléchon, A.; Wei, X. X.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • A promising step forward with giant leaps ahead
    Editorial

    Shaverdian, N.; Li, B. T.; Isbell, J.; Chaft, J. E.
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Three-year overall survival outcomes and correlative analyses in patients with NSCLC and high (50%–89%) versus very high (≥90%) programmed death-ligand 1 expression treated with first-line pembrolizumab or cemiplimab
    Journal Article

    Ricciuti, B.; Elkrief, A.; Lin, J.; Zhang, J.; Alessi, J. V.; Lamberti, G.; Gandhi, M.; Di Federico, A.; Pecci, F.; Wang, X.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • ALKTERNATE: A pilot study alternating lorlatinib with crizotinib in ALK-positive NSCLC with prior ALK inhibitor resistance
    Journal Article

    Itchins, M.; Liang, S.; Brown, C.; Barnes, T.; Marx, G.; Chin, V.; Kao, S.; Yip, P. Y.; Mersiades, A. J.; Nagrial, A.; more...
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Precision medicine for pancreatic cancer: Characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease
    Journal Article

    Keane, F.; Chou, J. F.; Walch, H.; Schoenfeld, J.; Singhal, A.; Cowzer, D.; Harrold, E.; O'Connor, C. A.; Park, W.; Varghese, A.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)
    Journal Article

    Fontana, E.; Rosen, E.; Lee, E. K.; Højgaard, M.; Mettu, N. B.; Lheureux, S.; Carneiro, B. A.; Cote, G. M.; Carter, L.; Plummer, R.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save